Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-06

Clinical Trial Update: A Randomized, Controlled, Double-blind Clinical Trial of Surinam Cherry Dentifrice With Anti-gingivitis Properties [Phase 1, Phase 2]

View source ↗

Summary

A randomized, controlled, double-blind Phase 1/2 trial evaluated a Surinam Cherry dentifrice for anti-gingivitis properties; the study is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Surinam Cherry Dentifrice

Snippet

Sponsor: Federal University of Paraíba | Conditions: Gingivitis | Phase 1, Phase 2 | Status: COMPLETED